FY21 Investor presentation
Filed with ASX · · 28 pages · English
ne 2 Disclaimer: This presentation has been prepared by Nova Eye Medical Limited (ASX: EYE). While the information in this presentation has been prepared in good faith and with reasonable care, no representation or warranty, express or implied, is made as to the accuracy, adequacy or reliability of any statement, estimates, opinions or other information contained in the presentation. This presenta
In the deck
Story so far
Earlier from Nova Eye Medical
- FY21 Trading Update
- First Patient enrolled in MAGIC Clinical Trial
- 2RT Post LEAD Review Shows Improved Treatment Benefits
- Clinical trial to Assess Efficacy and Safety of i Track
- Investor presentation Half year Results 31 December 2020
Later from Nova Eye Medical
- Full Year Results FY21
- FY21 Appendix 4E and Annual Report
- Aquisition of Glaucoma Patents
- US Government Stimulus Loan Forgiven
- EYE AGM Presentation
Follow Nova Eye Medical into a list and get an email when it puts out news.
Follow Nova Eye Medical